These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33738258)

  • 1. Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma.
    Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Lin JK; Yang SH
    Front Oncol; 2021; 11():620146. PubMed ID: 33738258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features and prognosis analysis of proximal colonic mucinous adenocarcinoma.
    Han F; Xu Y; Li X; Song Z; Xie J; Yao J
    Sci Rep; 2024 Aug; 14(1):18682. PubMed ID: 39134655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics and outcomes of colorectal mucinous adenocarcinoma: a retrospective analysis from China.
    Huang A; Yang Y; Sun Z; Hong H; Chen J; Gao Z; Gu J
    Front Oncol; 2024; 14():1335678. PubMed ID: 38380362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features of colorectal mucinous adenocarcinoma].
    Song W; He YL; Cai SR; Zhang CH; Chen CQ; Peng JJ; Zhan WH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):487-90. PubMed ID: 19742341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer.
    Huang A; Yang Y; Shi JY; Li YK; Xu JX; Cheng Y; Gu J
    World J Gastrointest Surg; 2021 Dec; 13(12):1567-1583. PubMed ID: 35070064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of adjuvant chemotherapy on survival in mucinous and non-mucinous rectal adenocarcinoma patients after TME surgery.
    Vernmark K; Knutsen A; Loftås P; Sun XF
    PLoS One; 2023; 18(2):e0282211. PubMed ID: 36848363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients with resected primary colorectal mucinous adenocarcinoma: A competing risk nomogram analysis.
    Dai D; Zhou B; Zhong Y; Jin H; Wang X
    Oncol Lett; 2019 Dec; 18(6):6594-6604. PubMed ID: 31807175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and molecular features between synchronous and metachronous metastases in colorectal cancer.
    Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Yang SH; Lin JK
    Am J Cancer Res; 2021; 11(4):1646-1658. PubMed ID: 33948379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after curative resection for stage I colorectal mucinous adenocarcinoma.
    Huang L; Luo S; Lai S; Liu Z; Hu H; Chen M; Kang L
    BMC Gastroenterol; 2022 Apr; 22(1):192. PubMed ID: 35436867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients.
    Zhou C; Lu L; Huang Q; Tang Z; Tang R; Xiao Z; Xiao S
    BMC Gastroenterol; 2023 Apr; 23(1):110. PubMed ID: 37020295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer.
    Park JS; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    Medicine (Baltimore); 2015 Apr; 94(15):e658. PubMed ID: 25881840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and molecular differences in colorectal cancer according to location.
    Hsu YL; Lin CC; Jiang JK; Lin HH; Lan YT; Wang HS; Yang SH; Chen WS; Lin TC; Lin JK; Lin PC; Chang SC
    Int J Biol Markers; 2019 Mar; 34(1):47-53. PubMed ID: 30854932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological, molecular features and prognosis of colorectal cancer with mucinous component.
    Li J; Yang L; Bai F; Cai Y; Zhang J; Wu Z; Fu Y; Deng Y
    Future Oncol; 2021 Apr; 17(11):1351-1362. PubMed ID: 33331169
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinicopathological and Molecular Features of Patients with Early and Late Recurrence after Curative Surgery for Colorectal Cancer.
    Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Yang SH; Lin JK
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Lymph Node Metastasis and Prognosis in pT1 Colorectal Cancer Patients with Signet-Ring Cell and Mucinous Adenocarcinomas.
    Song BR; Xiao CC; Wu ZK
    Cell Physiol Biochem; 2017; 41(5):1753-1765. PubMed ID: 28365687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous adenocarcinoma showing different clinicopathological and molecular characteristics in relation to different colorectal cancer subgroups.
    Chiang JM; Yeh CY; Changchien CR; Chen JS; Tang R; Chen JR
    Int J Colorectal Dis; 2010 Aug; 25(8):941-7. PubMed ID: 20532535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series.
    Negri F; De Giorgi A; Gilli A; Azzoni C; Bottarelli L; Gnetti L; Goldoni M; Manotti L; Sgargi P; Michiara M; Leonardi F; Rindi G; Cascinu S; Silini EM
    Sci Rep; 2019 Mar; 9(1):3668. PubMed ID: 30842570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features and Prognosis of Resectable Primary Colorectal Signet-Ring Cell Carcinoma.
    Lee HS; Soh JS; Lee S; Bae JH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim SA; Park YS; Lim SB; Kim JC; Yu CS; Yang DH
    Intest Res; 2015 Oct; 13(4):332-8. PubMed ID: 26576139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a prognostic signature and ENTR1 as a prognostic biomarker for colorectal mucinous adenocarcinoma.
    Huang A; Shi J; Sun Z; Yang Y; Gao Z; Gu J
    Front Oncol; 2023; 13():1061785. PubMed ID: 37182178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy.
    Lee DW; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
    Br J Cancer; 2013 May; 108(10):1978-84. PubMed ID: 23652310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.